1BUV Global News No Ads or Trackers
No Ads or Trackers
Pfizer Developing Specialized Vaccine Targeting Delta Variant of COVID-19

Pfizer Developing Specialized Vaccine Targeting Delta Variant of COVID-19


On Monday, the COVID-19 vaccine developed by Pfizer and BioNTech became the first vaccine of its kind to receive full approval from the US Food and Drug Administration (FDA). US President Joe Biden has since urged leaders in the public and private sector to use the FDA approval to implement vaccine requirements and curb the Delta variant’s spread.

Source link

Leave a comment

1BUV Global News